Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_assertion description "[The ability of a high affinity human recombinant antibody (2D03), specific for malondialdehyde-modified apoB-100, to influence formation of atherosclerosis as well as remodelling and neointima formation after a collar-induced injury of the carotid artery was studied in LDL receptor(-/-) mice over-expressing human apoB-100.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_assertion evidence source_evidence_literature NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_assertion SIO_000772 16677655 NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_assertion wasDerivedFrom befree-2016 NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_assertion wasGeneratedBy ECO_0000203 NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.
- befree-2016 importedOn "2016-02-19" NP548366.RA5ZONmKm4AU2Hk69k_nOUsf63oHA4KRHI5u1KLHz9VlE130_provenance.